PHARMATHENE Trademark

Trademark Overview


On Friday, July 25, 2008, a trademark application was filed for PHARMATHENE with the United States Patent and Trademark Office. The USPTO has given the PHARMATHENE trademark a serial number of 77531872. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 12, 2021. This trademark is owned by PharmAthene, Inc.. The PHARMATHENE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in biodefense, namely, antibody based pharmaceutical products, monoclonal antibodies, vaccines, pharmaceutical preparations for treatment and prevention of Alzheimer's disease, pharmaceutical preparations for treatment and prevention of poisoning, pharmaceutical preparations for treatment and prevention of neurological disease, pharmaceutical preparations for treatment and prevention of infectious disease, recombinant based therapeutics, pharmaceutical preparations acting on the central nervous system, pharmaceutical preparations for treatment and prevention of anthrax infection, pharmaceutical preparations for treatment and prevention of toxicity caused by cholinesterase inhibiting compounds
pharmathene

General Information


Serial Number77531872
Word MarkPHARMATHENE
Filing DateFriday, July 25, 2008
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 12, 2021
Registration Number3927270
Registration DateTuesday, March 8, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 21, 2010

Trademark Statements


Certificate of Correction for RegistrationIn the statement, lines 4 through 21 should be deleted, and "Pharmaceutical preparations for use in biodefense, namely, antibody based pharmaceutical products, monoclonal antibodies, vaccines, pharmaceutical preparations for treatment and prevention of Alzheimer's disease, pharmaceutical preparations for treatment and prevention of poisoning, pharmaceutical preparations for treatment and prevention of neurological disease, pharmaceutical preparations for treatment and prevention of infectious disease, recombinant based therapeutics, pharmaceutical preparations acting on the central nervous system, pharmaceutical preparations for treatment and prevention of anthrax infection, pharmaceutical preparations for treatment and prevention of toxicity caused by cholinesterase inhibiting compounds, in Class 5" should be inserted.
Goods and ServicesPharmaceutical preparations for use in biodefense, namely, antibody based pharmaceutical products, monoclonal antibodies, vaccines, pharmaceutical preparations for treatment and prevention of Alzheimer's disease, pharmaceutical preparations for treatment and prevention of poisoning, pharmaceutical preparations for treatment and prevention of neurological disease, pharmaceutical preparations for treatment and prevention of infectious disease, recombinant based therapeutics, pharmaceutical preparations acting on the central nervous system, pharmaceutical preparations for treatment and prevention of anthrax infection, pharmaceutical preparations for treatment and prevention of toxicity caused by cholinesterase inhibiting compounds
Pseudo MarkPHARMACEUTICAL ATHENE
Translation of Words in MarkThe term "PHARMATHENE" has no known significance other than as a term coined by the applicant.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 12, 2021
Primary Code005
First Use Anywhere DateTuesday, November 25, 2003
First Use In Commerce DateTuesday, October 26, 2004

Trademark Owner History


Party NamePharmAthene, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAnnapolis, NJ 07039

Party NamePharmAthene, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAnnapolis, MD 21401

Party NamePharmAthene, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAnnapolis, MD 21401

Trademark Events


Event DateEvent Description
Friday, November 12, 2021CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Sunday, March 8, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, April 26, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, April 26, 2017REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, April 26, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, March 7, 2017TEAS SECTION 8 & 15 RECEIVED
Saturday, June 4, 2011CORRECTION UNDER SECTION 7 ¿ PROCESSED
Saturday, June 4, 2011CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, May 27, 2011TEAS SECTION 7 REQUEST RECEIVED
Tuesday, March 8, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, December 21, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 21, 2010PUBLISHED FOR OPPOSITION
Wednesday, November 17, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 10, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 9, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 8, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 8, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 8, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 22, 2010APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 14, 2010PAPER RECEIVED
Thursday, May 6, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 6, 2010NON-FINAL ACTION E-MAILED
Thursday, May 6, 2010NON-FINAL ACTION WRITTEN
Friday, November 6, 2009REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, May 6, 2009NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, May 6, 2009LETTER OF SUSPENSION E-MAILED
Wednesday, May 6, 2009SUSPENSION LETTER WRITTEN
Sunday, May 3, 2009EXAMINER'S AMENDMENT ENTERED
Friday, May 1, 2009ASSIGNED TO LIE
Friday, May 1, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, May 1, 2009EXAMINERS AMENDMENT E-MAILED
Friday, May 1, 2009EXAMINERS AMENDMENT -WRITTEN
Monday, November 3, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 3, 2008NON-FINAL ACTION E-MAILED
Monday, November 3, 2008NON-FINAL ACTION WRITTEN
Wednesday, October 29, 2008ASSIGNED TO EXAMINER
Wednesday, July 30, 2008NOTICE OF PSEUDO MARK MAILED
Tuesday, July 29, 2008NEW APPLICATION ENTERED IN TRAM